Evidence map›Paper›PMID 27068529›Full record

ArticleJournal of the American Chemical Society2016

[Ru(Me4phen)2dppz](2+), a Light Switch for DNA Mismatches.

Adam N Boynton, Lionel Marcélis, Jacqueline K Barton

Abstract read
In one paragraph

Article in Journal of the American Chemical Society, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. Precious-Metal-Free COJACS Au · 2023
    Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. AnChemical science · 2020
    Article
  13. Switch-on effect on conformation-specific arylamine-DNA adduct by cyclometalated Ir(III) complexes.Journal of biological inorganic chemistry : JBIC : a publication of the Society of Biological Inorganic Chemistry · 2020
    Article
  14. Article
  15. Article
  16. Review
  17. Synthesis and photophysical studies of a multivalent photoreactive RuBeilstein journal of organic chemistry · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Adam N BoyntonDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
Lionel MarcélisDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.
Jacqueline K BartonDivision of Chemistry and Chemical Engineering, California Institute of Technology , Pasadena, California 91125, United States.

Funding

METAL PROBES AND DRUG BINDING TO DNA CHANGE OF GRANTEE IR01GM033309 · NIGMS · COLUMBIA UNIV NEW YORK MORNINGSIDE · PI BARTON, JACQUELINE K · 1985 to 2014
$3.2M
METAL PROBES AND DRUG BINDING TO DNAR37GM033309 · NIGMS · CALIFORNIA INSTITUTE OF TECHNOLOGY · PI BARTON, JACQUELINE K · 1996 to 2005
$2.6M
NIGMS NIH HHS GM033309NIGMS NIH HHS R01 GM033309NIGMS NIH HHS R37 GM033309
6 · The paper itself

Abstract

[Ru(Me4phen)2dppz](2+) serves as a luminescent "light switch" for single base mismatches in DNA. The preferential luminescence enhancement observed with mismatches results from two factors: (i) the complex possesses a 26-fold higher binding affinity toward the mismatch compared to well-matched base pairs, and (ii) the excited state emission lifetime of the ruthenium bound to the DNA mismatch is 160 ns versus 35 ns when bound to a matched site. Results indicate that the complex binds to the mismatch through a metalloinsertion binding mode. Cu(phen)2(2+) quenching experiments show that the complex binds to the mismatch from the minor groove, characteristic of metalloinsertion. Additionally, the luminescence intensity of the complex with DNA containing single base mismatches correlates with the thermodynamic destabilization of the mismatch, also consistent with binding through metalloinsertion. This complex represents a potentially new early cancer diagnostic for detecting deficiencies in mismatch repair.

Indexed as

DNA DamageDNA Mismatch RepairBase SequenceDNAKineticsLuminescenceOrganometallic CompoundsPhenazinesSubstrate SpecificityThermodynamicsbis(2,2'-bipyridyl)(dipyrido(3,2-alpha-2',3'-c)phenazine)ruthenium (II)DNAOrganometallic CompoundsPhenazines

Identifiers

PMID27068529
PMCPMC4989906

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.